Microvascular spasm as a cause of cardiomyopathies and the calcium-blocking agent verapamil as potential primary therapy
- 1 January 1985
- journal article
- review article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 55 (3) , B179-B184
- https://doi.org/10.1016/0002-9149(85)90629-0
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Microvascular spasm in the cardiomyopathic Syrian hamster: a preventable cause of focal myocardial necrosis.Circulation, 1982
- The cardiac hypertrophy process. Analyses of factors determining pathological vs. physiological development.Circulation Research, 1979
- The pathology of cardiomyopathies. A critical analysisAmerican Heart Journal, 1979
- HEREDITARY AND ACQUIRED CARDIOMYOPATHIES IN EXPERIMENTAL ANIMALS: MECHANICAL, BIOCHEMICAL, AND STRUCTURAL FEATURES *Annals of the New York Academy of Sciences, 1979
- Pathologic Anatomy of the CardiomyopathiesHuman Pathology, 1975
- Left ventricular ejection fraction as a prognostic guide in surgical treatment of coronary and valvular heart diseaseThe American Journal of Cardiology, 1974
- Myocardial contractility in relation to hypertrophy and failure in myopathic Syrian hamstersJournal of Molecular and Cellular Cardiology, 1972
- Myocardial Changes Associated with Cardiogenic ShockNew England Journal of Medicine, 1971
- Contractile State of Cardiac Muscle Obtained from Cats with Experimentally Produced Ventricular Hypertrophy and Heart FailureCirculation Research, 1967
- Primary Myocardial DiseaseCirculation, 1961